Hemophagocytic syndromes

Blood Reviews

Volumn 21, Issue 5, 2007, Pages 245-253

  Janka, Gritta E ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Hemophagocytosis; Histiocytosis; Immune deficiency; Macrophage activation syndrome; Review

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG MEGADOSE; ERYTHROPHAGOCYTOSIS; FAMILIAL DISEASE; FEVER; GENE MUTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION; LEISHMANIASIS; LYMPHOMA; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REPEATED DRUG DOSE; RHEUMATIC DISEASE; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SYMPTOM; SYNDROME DELINEATION; TREATMENT OUTCOME;

CYCLOSPORINE; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOMEGALY; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PROGNOSIS; SPLENOMEGALY;

EID: 34547691044     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2007.05.001     Document Type: Article

References (51)

1. Janka G.E. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140 (1983) 221-230
2. Arico M., Janka G., Fischer A., et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 10 (1996) 197-203
3. Allen M., De Fusco C., Legrand F., et al. Familial hemophagocytic lymphohistiocytosis: how late can the onset be?. Haematologica 86 (2001) 499-503
4. Clementi R., Emmi L., Maccario R., et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 100 (2002) 2266-2267
5. Risdall R.J., McKenna R.W., Nesbit M.E., et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44 (1979) 993-1002
6. Janka G., Imashuku S., Elinder G., Schneider M., and Henter J.I. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 12 (1998) 435-444
7. Fisman D.N. Hemophagocytic syndromes and infection. Emerg Infect Dis 6 (2000) 601-608
8. Gagnaire M.H., Galambrun C., and Stephan J.L. Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children-a series of 12 cases. Pediatrics 106 (2000) E58
9. Janka G. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr (2006) Epub ahead of print
10. Arico M., Nespoli L., Maccario R., et al. Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child 63 (1988) 292-296
11. Henter J.I., Ehrnst A., Andersson J., and Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 82 (1993) 369-372
12. Jaffe E.S., Costa J., Fauci A.S., Cossman J., and Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 75 (1983) 741-749
13. Falini B., Pileri S., De Solas I., et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75 (1990) 434-444
14. Takahashi N., Chubachi A., Miura I., Nakamura S., and Miura A.B. Lymphoma-associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 40 (1999) 542-549
15. Quintanilla-Martinez L., Kumar S., Fend F., et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96 (2000) 443-451
16. Henter J.I., Arico M., Elinder G., Imashuku S., and Janka G. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 12 (1998) 417-433
17. Komp D.M., McNamara J., and Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73 (1989) 2128-2132
18. Schneider E.M., Lorenz I., Muller-Rosenberger M., Steinbach G., Kron M., and Janka-Schaub G.E. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 100 (2002) 2891-2898
19. Henter J.I., Elinder G., Soder O., Hansson M., Andersson B., and Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78 (1991) 2918-2922
20. Jordan M.B., Hildeman D., Kappler J., and Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104 (2004) 735-743
21. Kaito K., Kobayashi M., Katayama T., et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 59 (1997) 247-253
22. Takahashi N., Chubachi A., Kume M., et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74 (2001) 209-213
23. Stinchcombe J., Bossi G., and Griffiths G.M. Linking albinism and immunity: the secrets of secretory lysosomes. Science 305 (2004) 55-59
24. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286 (1999) 1957-1959
25. Feldmann J., Callebaut I., Raposo G., et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115 (2003) 461-473
26. zur Stadt U., Schmidt S., Kasper B., et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 14 (2005) 827-834
27. Ohadi M., Lalloz M.R., Sham P., et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 64 (1999) 165-171
28. Zur Stadt U., Beutel K., Kolberg S., et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 27 (2006) 62-68
29. Nagle D.L., Karim M.A., Woolf E.A., et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 14 (1996) 307-311
30. Menasche G., Pastural E., Feldmann J., et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 25 (2000) 173-176
31. Coffey A.J., Brooksbank R.A., Brandau O., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20 (1998) 129-135
32. Hadchouel M., Prieur A.M., and Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 106 (1985) 561-566
33. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 14 (2002) 548-552
34. Ramanan A., Laxer R., and Schneider R. Secondary hemophagocytic syndromes associated with rheumatic diseases. In: Weitzman S., and Egeler R.M. (Eds). Histiocytic disorders of children and adults (2005), Cambridge University Press, Cambridge 380-395
35. Emmenegger U., Schaer D.J., Larroche C., and Neftel K.A. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 135 (2005) 299-314
36. Ravelli A., Magni-Manzoni S., Pistorio A., et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146 (2005) 598-604
37. Stephan J.L., Kone-Paut I., Galambrun C., Mouy R., Bader-Meunier B., and Prieur A.M. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40 (2001) 1285-1292
38. Grom A.A., Villanueva J., Lee S., Goldmuntz E.A., Passo M.H., and Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142 (2003) 292-296
39. Wulffraat N.M., Rijkers G.T., Elst E., Brooimans R., and Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) 42 (2003) 375-379
40. Takei M., Ishiwata T., Mitamura K., et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol 13 (2001) 559-565
41. Henter J.I., Horne A., Arico M., et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2006)
42. Hibi S., Ikushima S., Fujiwara F., et al. Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 75 (1995) 1700-1705
43. Teruya-Feldstein J., Setsuda J., Yao X., et al. MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. Lab Invest 79 (1999) 1583-1590
44. Feldmann J., Menasche G., Callebaut I., et al. Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. Blood 105 (2005) 2658-2663
45. Henter J.I., and Elinder G. Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet 339 (1992) 104-107
46. Parizhskaya M., Reyes J., and Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 2 (1999) 360-366
47. Loechelt B.J., Egeler M., Filipovich A.H., Jyonouchi H., and Shapiro R.S. Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL). Med Pediatr Oncol 22 (1994) 325-328
48. Mouy R., Stephan J.L., Pillet P., Haddad E., Hubert P., and Prieur A.M. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129 (1996) 750-754
49. Imashuku S., Kuriyama K., Teramura T., et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19 (2001) 2665-2673
50. Henter J.I., Samuelsson-Horne A., Arico M., et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100 (2002) 2367-2373
51. Horne A., Janka G., Maarten Egeler R., et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 129 (2005) 622-630